B & T Capital Management DBA Alpha Capital Management
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1450935
AUSTIN, TX
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,979,274
-$751,031 QoQ
Shares Held
4,778
-1.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#458
of 1,322 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026B & T Capital Management DBA Alpha Capital Management holds $2,979,274 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,778 | $2,979,274 |
All Filings in REGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,979,274 | 4,778 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,730,305 | 4,828 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,162,694 | 5,393 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,099,232 | 5,512 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,874,900 | 5,476 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,226,147 | 3,510 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,241,702 | 3,147 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,298,281 | 1,235 | Shares | Sole | 2024-10-09 | |
| 2020-12-31 | $267,642 | 554 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $629,192 | 1,124 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $282,513 | 453 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||